The Global Tobramycin Eye Drop Market, which was estimated at USD 12.21  Billion in 2024 and is forecasted to climb to USD 19.05 Billion by 2032. This robust expansion is reflected in a high Compound Annual Growth Rate (CAGR) of 5.07% over the forecast period (2025-2032). The substantial growth in the Tobramycin Eye Drop...